6-anilino-5,8-quinolinedione has been researched along with Akinetic-Rigid Variant of Huntington Disease in 1 studies
6-anilino-5,8-quinolinedione: structure given in first source; SRS-A & guanylate cyclase antagonist
6-anilino-5,8-quinolinedione : A quinolone that is quinoline-5,8-dione in which the hydrogen at position 6 is replaced by an anilino group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sarkar, S | 1 |
Perlstein, EO | 1 |
Imarisio, S | 1 |
Pineau, S | 1 |
Cordenier, A | 1 |
Maglathlin, RL | 1 |
Webster, JA | 1 |
Lewis, TA | 1 |
O'Kane, CJ | 1 |
Schreiber, SL | 1 |
Rubinsztein, DC | 1 |
1 other study available for 6-anilino-5,8-quinolinedione and Akinetic-Rigid Variant of Huntington Disease
Article | Year |
---|---|
Small molecules enhance autophagy and reduce toxicity in Huntington's disease models.
Topics: Animals; Autophagy; Huntington Disease; Mammals; Models, Biological; Neuroprotective Agents; Sacchar | 2007 |